ArticleScientific reports2021

Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice.

Juan Carlos Bazo-Alvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.